AVA Genomics Consultancy ApS: Financial statements 2019
CVR: 37493678
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
AVA Genomics Consultancy ApS (CVR 37493678) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 18,441 and a net result of DKK 10,088 compared with DKK -1,990 the year before. Equity in the 2019 report amounted to DKK 9,974. The solvency ratio was 47%.
- Gross Profit
- DKK 18,441
- Profit/Loss
- DKK 10,088
- Equity
- DKK 9,974
- Total Assets
- DKK 21,216
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 18 t. | 10 t. | 10 t. | 0 |
| 2018 | - | -2 t. | -2 t. | -114 | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout AVA Genomics Consultancy ApS
AVA Genomics Consultancy ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AVA Genomics and Breeding Consultancy IVS. The management consists of Haja Najeemudin Kadarmideen. The company is owned by Haja Najeemudin Kadarmideen. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 14,728 and a net result of DKK -4,294 compared with DKK -18,733 the year before. Equity in the 2026 report amounted to DKK 90,595.